Ratings
0
Nobody has rated this yet. Be the first!
Works
3
Dabrafenib in BRAF-mutated metastatic melanoma: a multicentre, open-label, phase 3 randomised controlled trial
Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials.
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma
